Targeting the metabolic vulnerability of acute myeloid leukemia blasts with a combination of venetoclax and 8-chloro-adenosine

被引：0
|
作者：
Ralf Buettner
Le Xuan Truong Nguyen
Corey Morales
Min-Hsuan Chen
Xiwei Wu
Lisa S. Chen
Dinh Hoa Hoang
Servando Hernandez Vargas
Vinod Pullarkat
Varsha Gandhi
Guido Marcucci
Steven T. Rosen
机构：
[1] City of Hope Medical Center,Hematology Malignancies Research Institute, Gehr Family Center for Leukemia Research
[2] City of Hope Medical Center,Integrative Genomics Core, Beckman Research Institute
[3] The University of Texas MD Anderson Cancer Center,Department of Experimental Therapeutics
来源：
Journal of Hematology & Oncology | / 14卷
关键词：
Acute myeloid leukemia; Oxidative phosphorylation; Fatty acid oxidation; Nucleoside analog; Metabolism;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] An evaluation of venetoclax in combination with azacitidine, decitabine, or low-dose cytarabine as therapy for acute myeloid leukemia
    Othman, Tamer A.
    Tenold, Matthew E.
    Moskoff, Benjamin N.
    Azenkot, Tali
    Jonas, Brian A.
    EXPERT REVIEW OF HEMATOLOGY, 2021, 14 (05) : 407 - 417
  • [22] Venetoclax in combination with hypomethylating agent for the treatment of advanced myeloproliferative neoplasms and acute myeloid leukemia with extramedullary disease
    Sanber, Khaled
    Ye, Kevin
    Tsai, Hua-Ling
    Newman, Matthew
    Webster, Jonathan A.
    Gojo, Ivana
    Ghiaur, Gabriel
    Prince, Gabrielle T.
    Gondek, Lukasz P.
    Smith, B. Douglas
    Levis, Mark J.
    DeZern, Amy E.
    Ambinder, Alexander J.
    Dalton, William B.
    Jain, Tania
    LEUKEMIA & LYMPHOMA, 2023, 64 (04) : 846 - 855
  • [23] Targeting chemoresistance and mitochondria-dependent metabolic reprogramming in acute myeloid leukemia
    Feng, Lili
    Zhang, Philip Y.
    Gao, Wenda
    Yu, Jinming
    Robson, Simon C.
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [24] Combined Metabolic Targeting With Metformin and the NSAIDs Diflunisal and Diclofenac Induces Apoptosis in Acute Myeloid Leukemia Cells
    Renner, Kathrin
    Seilbeck, Anton
    Kauer, Nathalie
    Ugele, Ines
    Siska, Peter J.
    Brummer, Christina
    Bruss, Christina
    Decking, Sonja-Maria
    Fante, Matthias
    Schmidt, Astrid
    Hammon, Kathrin
    Singer, Katrin
    Klobuch, Sebastian
    Thomas, Simone
    Gottfried, Eva
    Peter, Katrin
    Kreutz, Marina
    FRONTIERS IN PHARMACOLOGY, 2018, 9
  • [25] Venetoclax in Combination with Azacitidine for the Treatment of Newly Diagnosed Acute Myeloid Leukemia: A Canadian Cost-Utility Analysis
    Guinan, Kimberly
    Mathurin, Karine
    Au, Yunghan
    Schuh, Andre C.
    Bui, Cat N.
    Chai, Xinglei
    Lachaine, Jean
    CURRENT ONCOLOGY, 2022, 29 (10) : 7524 - 7536
  • [26] Real-world analysis of tumor lysis syndrome in patients started on venetoclax combination for acute myeloid leukemia
    Abernathy, Karin M.
    Perciavalle, Matthew A.
    Gatwood, Katie S.
    Chen, Heidi
    Zakhari, Matthew M.
    Byrne, Michael
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2023, 29 (06) : 1326 - 1333
  • [27] The efficacy of the combination of venetoclax and hypomethylating agents versus HAG agents in patients with acute myeloid leukemia: a retrospective study
    Xin, Fei
    Yu, Yan-Hui
    Shen, Xu-Liang
    Zhang, Guo-Xiang
    HEMATOLOGY, 2024, 29 (01)
  • [28] Combination of Venetoclax and Hypomethylating Agents in Relapsed/Refractory Acute Myeloid Leukemia: Single-Center Clinical Experience
    Secilmis, Sema
    Bozan, Ersin
    Darcin, Tahir
    Yaman, Samet
    Yigenoglu, Tugcenur
    Ulu, Bahar Uncu
    Sahin, Derya
    Bakirtas, Mehmet
    Basci, Semih
    Yildiz, Jale
    Baysal, Nuran Ahu
    Iskender, Dicle
    Cakar, Merih Kizil
    Sinan, Dal Mehmet
    Altuntas, Fevzi
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S192 - S193
  • [29] Meta-analysis of the efficacy of venetoclax and azacitidine combination therapy and azacitidine monotherapy for treating acute myeloid leukemia
    Xie, Yuqin
    Wei, Xueqin
    Wang, Weiwei
    Liao, Changsheng
    Han, Pengfei
    Yu, Yanhui
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2024, 27 (04)
  • [30] Venetoclax in Combination with Hypomethylating Agents for the Treatment of Treatment-Naive B/Myeloid Mixed-Phenotype Acute Leukemia and Relapsed/Refractory Acute Myeloid Leukemia: A Report of 3 Cases
    Wang, Na
    He, Jing
    Liu, Fang
    CHEMOTHERAPY, 2022, 67 (03) : 178 - 182
12345